Medical Alert Systems Market (By Type: Personal Emergency Response Systems (PERS), Nurse Calling Systems (NCS), Smart Belt; By Technology: Two-way Voice Systems, Unmonitored Medical Alert Systems, Medical Alert Alarm (Button) System, IP-based Systems; By Application: Home-Based Users, Senior Living Facilities/Senior Care Centers, Assisted Living Facilities, Hospitals and Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Alert Systems Market
5.1. COVID-19 Landscape: Medical Alert Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Alert Systems Market, By Type
8.1. Medical Alert Systems Market Revenue and Volume, by Type, 2024-2033
8.1.1. Personal Emergency Response Systems (PERS)
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Nurse Calling Systems (NCS)
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Smart Belt
8.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Medical Alert Systems Market, By Technology
9.1. Medical Alert Systems Market Revenue and Volume, by Technology, 2024-2033
9.1.1. Two-way Voice Systems
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Unmonitored Medical Alert Systems
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Medical Alert Alarm (Button) System
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. IP-based Systems
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Medical Alert Systems Market, By Application
10.1. Medical Alert Systems Market Revenue and Volume, by Application, 2024-2033
10.1.1. Home-Based Users
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Senior Living Facilities/Senior Care Centers
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Assisted Living Facilities
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Hospitals and Clinics
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Medical Alert Systems Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by March (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by January (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by February (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by March (2021-2033)
Chapter 12. Company Profiles
12.1. Philips Lifeline
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Medical Guardian
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. ADT
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Life Alert
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bay Alarm Medical
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. MobileHelp
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. GreatCall (acquired by Best Buy)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Tunstall Healthcare
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Alert1
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Connect America
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client